Table 1.
Clinical and biological characteristics of patients at admission
| N = 124 patients | |
| Age (Y) | 32 ± 2.8 |
| Gender (M/F) | 5 / 119 |
| AN-R type | 90 (73%) |
| AN-BP type | 34 (27%) |
| Duration of AN since diagnostic (Y) | 7.9 ± 5.7 |
| BMI | 12.3 ± 2,5 |
| HR (bpm) | 61.6 ± 17.2 |
| SBP (mm Hg) | 99.2 ± 12 |
| DBP (mmHg) | 65.6 ± 10.6 |
| Body composition (DEXA) | |
| FFM (Kg) | 28.8 ± 4.8 |
| FM (%) | 8.8 ± 3.8 |
| FFMI (%) | 10.8 ± 1.4 |
| Cardiac findings | |
| QT interval (mm) | 406 ± 54 |
| QTc interval (mm) | 385 ± 31 |
| QT/QTc | 1 ± 0.1 |
| Pericardial effusion | 34 (27%) |
| LVEF (%) | 63 ± 10 |
| LV mass (g) | 80 ± 22 |
| Biological findings | |
| Albumin (38–52 g/l) | 36.9 ± 7.1 |
| Transthyretin (0.21–0.45 g/l) | 0.248 ± 0.102 |
| CRP (< 5 mg/l) | 6.5 ± 23.7 |
| BNP (< 100 pg /l) | 54 ± 70 |
| Potassium (3.7–4.7 mmol/l) | 3.8 ± 0.6 |
| Calcium (2.12–2.52 mmol/l) | 2.2 ± 0.1 |
| Phosphorus (0.8–1.45 mmol/l) | 1.1 ± 0.3 |
| Magnesium (0.70–1.00 mmol/l) | 0.8 ± 0,1 |
| Patients with Hypertransaminasemiaa | 34 (27%) |
| AST (15–37 UI/l) | 137.6 ± 425.8 |
| ALT (12–78 UI/l) | 170.1 ± 371.4 |
| Total Cholesterol (C) (3.00–6.00 mmol/l) | 4.2 ± 1.4 |
| HDL-C (0.8–1.9 mmol/l) | 1.8 ± 0.7 |
| LDL-C (< 4.1 mmol/l) | 2.1 ± 1.1 |
| Total TG (< 1.7 mmol/l) | 0.9 ± 0.7 |
Data are expressed as mean + SD or number (percentage)
Y Years, M Men, F Females, AN-R Anorexia Nervosa Restrictive type, AN-BP Anorexia Nervosa Binge Eating/Purging type, BMI Body Mass Index, HR Heart Rate, SBD Systolic Blood Pressure, DBP Diastolic Blood Pressure, FFM Free Fat Mass, FM Fat Mass, FFMI Free Fat Mass Index, QTc corrected QT interval, LVEF Left Ventricular ejection fraction, LV Left Ventricle, CRP C-Reactive Protein, BNP Brain Natriuretic Peptid, AST Aspartate Transaminase, ALT Alanine Transaminase, HDL High Density Lipoprotein, LDL Low Density Lipoprotein, TG triglycerides
a = (AST and/or ALT> 2 N)